Company / Revenue per Share
Whitehawk Therapeutics, Inc. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$1.05
FY2025
5-year range
$0.57 / $5.73
FY2021-FY2025
Trend
+6.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 8 years, ranging from $0.00 in FY2020 to $5.73 in FY2021.
Based on SEC 10-K filings.
1.05 in FY2025 with a 3-year CAGR of -42.7%.
Improved from $0.57 to $1.05 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -42.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 6.1% year-over-year.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.05 | +6.1% |
| FY2024 | $0.99 | +73.1% |
| FY2023 | $0.57 | -89.8% |
| FY2022 | $5.60 | -2.4% |
| FY2021 | $5.73 | - |
| FY2020 | $0.00 | -100.0% |
| FY2019 | $0.50 | +908.3% |
| FY2018 | $0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026